Related Experiment Video
Updated: Aug 2, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Post-COVID Interstitial Lung Disease-The Tip of the Iceberg
Namrata Kewalramani1, Kerri-Marie Heenan2, Denise McKeegan2
1Department for BioMedical Research DBMR, Inselspital, Bern University Hospital, University of Bern, Switzerland; Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland.
Insights
Long COVID, a significant health burden, involves persistent symptoms after COVID-19 infection. This review examines emerging evidence on post-COVID interstitial lung disease, its mechanisms, and impact.
Area of Science:
- Pulmonology
- Infectious Diseases
- Pathophysiology
Background:
- Post-COVID condition (long COVID) presents a substantial burden on patients and healthcare systems.
- Understanding the long-term effects of COVID-19 is crucial for effective patient management.
- Emerging respiratory complications require focused investigation.
Purpose of the Study:
- To review the current evidence on the development of post-COVID interstitial lung disease.
- To explore the pathophysiological mechanisms, incidence, and diagnostic approaches.
- To assess the impact of this emerging respiratory condition.
Main Methods:
- Systematic literature review of emerging evidence.
- Analysis of pathophysiological mechanisms.
- Evaluation of diagnostic criteria and incidence data.
Main Results:
- Growing evidence suggests interstitial lung disease as a sequela of COVID-19.
- Specific pathophysiological pathways are being identified.
- Incidence and long-term impact data are still developing.
Conclusions:
- Post-COVID interstitial lung disease is an emerging concern requiring further research.
- Understanding its development is key to managing long-term respiratory health after COVID-19.
- Early diagnosis and intervention strategies are needed.
Abstract:
The proportion of symptomatic patients with post-coronavirus 2019 (COVID-19) condition (long COVID) represents a significant burden on the individual as well as on the health care systems. A greater understanding of the natural evolution of symptoms over a longer period and the impacts of interventions will improve our understanding of the long-term impacts of the COVID-19 disease. This review will discuss the emerging evidence for the development of post-COVID interstitial lung disease focusing on the pathophysiological mechanisms, incidence, diagnosis, and impact of this potentially new and emerging respiratory disease.
More Related Videos
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: